Financing demonstrates the value of Laminar Wash technology in accelerating and standardizing therapeutic research and development WOBURN, Mass. — Curiox Biosystems, Inc., the global leader in biological sample preparation automation, announced today the completion of a $15 million (17.1 billion won) Series C financing round. Luha Private Equity led the deal, joined by other existing investors KB Investment Co., […]
San Diego, Calif. – Arima Genomics, Inc., the leader in 3D genomics, today announced the close of its $7 million Series B Preferred Stock financing round. New investors Genetron Health (NASDAQ: GTH), Tech Coast Angels, Ladder Ventures, and Hiaqua Investments were joined by existing investors Agilent Technologies (NYSE: A), Co-win Ventures, Vectr Ventures and Berkeley […]
RNA is increasingly the focus of medicine, new therapeutics, and vaccines Eclipsebio leads the field of RNA genomics with a suite of data-driven technologies revealing RNA structure, modifications, interactions, and translation Eclipsebio plans to leverage this capital raise to accelerate the development of pipeline technologies and products SAN DIEGO — Eclipse Bioinnovations, Inc. (Eclipsebio), the leading […]
The Fully Enzymatic Synthesis™ (or FES™) technology by Molecular Assemblies is designed to overcome the length, purity, and accuracy limitations of the chemical DNA synthesis method The company is launching a key customer program to accelerate innovation in established industries and unlock new applications for synthetic DNA SAN DIEGO — Molecular Assemblies, Inc., today announced that it […]
Financing round led by Prosnav Capital, a strategic international investor based in Luxembourg and Hong Kong, and supported by investment from a group of continuing shareholders Financing accelerates the company’s development into a global leader in proteomics and provides direct access to Asian market opened through broad network of Prosnav Capital New management team appointed […]
Financing led by Beringea and Spring Mountain Capital to fuel continued growth in pharmaceutical and clinical diagnostic markets Genomenon®Inc., an AI-driven genomics company, today announced the completion of a $20 million Series B financing round. The funds will expand the company’s commercial operations and the development of its genomic data hub, which serves genetic testing labs, […]
The bioautomation company emerges from stealth mode with investment led by Maverick Ventures and John Stuepelnagel (co-founder of Illumina) CAMBRIDGE, MA – Volta Labs, a bioautomation company developing solutions to streamline the upstream workflows in genomic sequencing, today announced it raised $20 million in a Series A funding round. The round was led by Maverick […]
Tedia Announces Partnership with NewHold Enterprises Fairfield, OH & New York, NY, March 8, 2022 – Tedia Company, LLC (Tedia) today announced they have entered into a partnership with NewHold Enterprises, LLC (NewHold) through a strategic investment on March 4, 2022. Tedia is the largest manufacturer of OEM high-purity solvents in North America, selling its […]
CHARLOTTESVILLE, Va. — LumaCyte Corporation, a bioanalytical instrumentation leader in advanced label-free single-cell analytics, announced the successful completion of an A round financing that will allow the company to accelerate its global expansion efforts and service the increasing global demand of its flagship product, Radiance ®. LumaCyte will also use these funds to further expand the company’s […]
MOUNTAIN VIEW, Calif. — DNAnexus, Inc., a leading provider of cloud-based biomedical data analysis software serving the life sciences community, today announced a $200 million financing round to accelerate the global adoption of its technology, translating the world’s complex multi-omics and clinical data into tangible insights and personalized treatments. The round was led by funds […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
